Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

NCT00698490 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis Herpes Simplex

Interventions

BIOLOGICAL: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141
BIOLOGICAL: Herpes simplex virus containing gD-Alum

Sponsor

GlaxoSmithKline